by The global genotyping market size accounted for US$ 16.9 Bn in 2022 and is projected to reach around USD 67.60 Bn by 2032, growing at a CAGR of 14.87% from 2023 to 2032.
Report Summary
The global genotyping market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the genotyping market across the globe.
A comprehensive estimate on the genotyping market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of genotyping during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2983
Genotyping Market Report Scope
| Report Coverage | Detail |
| Market Size in 2023 | USD 19.41 Billion |
| Market Size by 2032 | USD 67.60 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 14.87% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 To 2032 |
| Segments Covered | By Product, By Application, By Technology, and By End Users |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized genotyping market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Cell-based Assays Market Size To Cross USD 42.32 Bn By 2032
Genotyping Market Players
The report includes the profiles of key genotyping market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Illumina Inc
- Thermo Fisher Scientific Inc.
- Qiagen Inc.
- F. Hoffmann-La Roche Ltd.
- Fluidigm Corporation
- Danaher Corporation
- Agilent Technologies
- Eurofins Scientific Inc.
- GE Healthcare Inc.
- Bio-Rad Laboratories Inc.
- Pacific Biosciences of California
Market Segmentation
By Product
- Instruments
- Sequencers & Amplifiers
- Analyzers
- Reagents & Kits
- Software and Services
- Genotyping Services
By Application
- Pharmacogenomics
- Diagnostics and Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Others
By Technology
- PCR
- Real-time PCR
- Digital PCR
- Capillary Electrophoresis
- Amplified Fragment Length Polymorphism
- Restriction Fragment Length Polymorphism
- Single-Strand Conformation Polymorphism
- Microarrays
- DNA Microarrays
- Peptide Microarrays
- Others
- Sequencing
- Next Generation Sequencing
- Pyro Sequencing
- Sanger Sequencing
- Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy
- Others
By End Users
- Pharmaceutical And Biopharmaceutical Companies
- Diagnostics And Research Laboratories
- Academic Institutes
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Genotyping Market
5.1. COVID-19 Landscape: Genotyping Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Genotyping Market, By Product
8.1. Genotyping Market, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Sequencers & Amplifiers
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Analyzers
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Reagents & Kits
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Software and Services
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Genotyping Services
8.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Genotyping Market, By Application
9.1. Genotyping Market, by Application, 2023-2032
9.1.1. Pharmacogenomics
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Diagnostics and Personalized Medicine
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Agricultural Biotechnology
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Animal Genetics
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Genotyping Market, By March
10.1. Genotyping Market, by March, 2023-2032
10.1.1. PCR
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Capillary Electrophoresis
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Microarrays
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Sequencing
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Genotyping Market, By End Users
11.1. Genotyping Market, by End Users, 2023-2032
11.1.1. Pharmaceutical And Biopharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Diagnostics And Research Laboratories
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Academic Institutes
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Genotyping Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.3. Market Revenue and Forecast, by March (2020-2032)
12.1.4. Market Revenue and Forecast, by End Users (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.3. Market Revenue and Forecast, by March (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.3. Market Revenue and Forecast, by March (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.3. Market Revenue and Forecast, by March (2020-2032)
12.2.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.3. Market Revenue and Forecast, by March (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.3. Market Revenue and Forecast, by March (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.3. Market Revenue and Forecast, by March (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.3. Market Revenue and Forecast, by March (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.3. Market Revenue and Forecast, by March (2020-2032)
12.3.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.3. Market Revenue and Forecast, by March (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.3. Market Revenue and Forecast, by March (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.3. Market Revenue and Forecast, by March (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.3. Market Revenue and Forecast, by March (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.3. Market Revenue and Forecast, by March (2020-2032)
12.4.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.3. Market Revenue and Forecast, by March (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.3. Market Revenue and Forecast, by March (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.3. Market Revenue and Forecast, by March (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.3. Market Revenue and Forecast, by March (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.3. Market Revenue and Forecast, by March (2020-2032)
12.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.3. Market Revenue and Forecast, by March (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.3. Market Revenue and Forecast, by March (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End Users (2020-2032)
Chapter 13. Company Profiles
13.1. Illumina Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Qiagen Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Fluidigm Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Danaher Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Agilent Technologies
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Eurofins Scientific Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GE Healthcare Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Bio-Rad Laboratories Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
